These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 789253)

  • 21. The biliary excretion of cefazolin.
    Brogard JM; Dorner M; Pinget M; Adloff M; Lavillaureix J
    J Infect Dis; 1975 Jun; 131(6):625-33. PubMed ID: 805810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefazolin and cephradine: relationship between serum concentrations and tissue contents in mice.
    Kunst MW; Mattie H
    Infection; 1978; 6(4):166-70. PubMed ID: 357295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of biliary disease on the excretion of cefazolin in human bile.
    McLeish AR; Strachan CJ; Powis SJ; Wise R; Bevan PG
    Surgery; 1977 Apr; 81(4):426-30. PubMed ID: 847650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on cephradine for intravenous injection (author's transl)].
    Sekine O; Usuda Y; Higuchi K; Watanabe M; Yamasaku F
    Jpn J Antibiot; 1976 Nov; 29(11):968-72. PubMed ID: 1003681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary excretion of a new semisynthetic cephalosporin, cephacetrile.
    Brogard JM; Haegele P; Dorner M; Lavillaureix J
    Antimicrob Agents Chemother; 1973 Jan; 3(1):19-23. PubMed ID: 4208278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration.
    Bergan T
    Chemotherapy; 1977; 23(6):389-404. PubMed ID: 923329
    [No Abstract]   [Full Text] [Related]  

  • 28. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis.
    Maluenda F; Csendes A; Burdiles P; Diaz J
    Hepatogastroenterology; 1989 Jun; 36(3):132-5. PubMed ID: 2502489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between antibacterial activity of some cephalosporins and pharmacokinetic properties "in vitro" (author's transl)].
    Tamassia V; Meinardi G; Grasso S; de Carneri I
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():785-92. PubMed ID: 400257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary excretion of cefuroxime. Experimental and human study.
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Lavillaureix J
    Chemotherapy; 1981; 27(1):18-28. PubMed ID: 7215002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary excretion of exogenous cadmium, and endogenous copper and zinc in the Eisai hyperbilirubinuric (EHB) rat with a near absence of biliary glutathione.
    Sugawara N; Lai YR; Arizono K; Ariyoshi T
    Toxicology; 1996 Aug; 112(1):87-94. PubMed ID: 8792851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amoxycillin levels in human serum, bile, gallbladder, lung, and liver tissue.
    Kiss IJ; Faragó E; Schnitzler J; Várhelyi I
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):69-74. PubMed ID: 7216553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary excretion of ceftizoxime in humans.
    Brogard JM; Arnaud JP; Timmler R
    Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
    Shoda Y; Matsuyama S; Takarada A; Arai M; Nagashima K; Nakano G; Nakamura T; Kamisaka K; Matsuzawa T; Yoshino T
    Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the biliary excretion of pencillin G.
    Brogard JM; Pinget M; Doffoel M; Adloff M; Lavillaureix J
    Chemotherapy; 1979; 25(3):129-39. PubMed ID: 456074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections].
    Oikawa M; Watanabe I
    Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study and human pharmacology of the biliary excretion of a cephalosporin, cephalexin. Therapeutical application].
    Brogard JM; Kuntzmann F; Dorner M; Haegele P; Lavillaureix J
    Pathol Biol (Paris); 1971 Dec; 19(23):1121-31. PubMed ID: 4945763
    [No Abstract]   [Full Text] [Related]  

  • 38. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the circulation of semisynthetic cephalosporins in the blood of rabbits].
    Klimov VS; Iakovlev VP; Rudzit EA
    Antibiotiki; 1975 Jun; 20(7):646-9. PubMed ID: 1225215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice.
    Chijiiwa K; Watanabe M; Nakano K; Noshiro H; Tanaka M
    Am J Surg; 2000 Feb; 179(2):161-6. PubMed ID: 10773154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.